FACTORS RELATED TO SERUM LEVELS OF INTERCELLULAR ADHESION MOLECULE-1 IN PROBABLE COVID-19 PATIENTS IN SURGICAL TREATMENT

Completed

• Conditions: Patients meet the suspect and probable COVID-19 criteria; COVID-19; ICAM-1; Surgery Patients

• Registration Number: TCTR20220925003
• Lead Sponsor: Self-funding

Brief Summary

There were no significant differences in serum ICAM-1 levels according to gender, either for initial examination, follow-up, or changes between the two tests.

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-06-30
• Study Start: 2022-09-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1)Patients are triage patients in the emergency department for surgical procedures
2)Patients meet the suspect and probable COVID-19 criteria
3)Patients are willing to undergo a swab examination for RT-PCR COVID-19
4)Patients give informed consent in writing for this study

Exclusion Criteria

1)The patient refuses to undergo a swab test or be treated
2)Patients with obstetric and gynecological care including delivery management
3)The patient dies during treatment

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum ELISA Peripheral vein blood sampling was performed before and immediately after surgery. ICAM-1 immunoassay

Secondary Outcome Measures

Name	Time	Method
Characteristic data via questionare performed before surgery. age, sex